Related Experiment Video
Updated: Jun 23, 2026
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Screening of Avoidance/Restrictive Food Intake Disorder (ARFID) in Patients with Quiescent Inflammatory Bowel Disease
P Van Ouytsel1,2, A Cremer3, D Franchimont3
1Department of Dietetics, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), CUB Hôpital Erasme (ULB), Brussels, Belgium. pauline.vanouytsel.diet@outlook.com.
Purpose:
Even in the absence of active inflammation, patients with inflammatory bowel diseases (IBD) frequently report symptoms consistent with irritable bowel syndrome (IBS), which may lead to restrictive dietary patterns and ultimately increase the risk of avoidant/restrictive food intake disorder (ARFID). The aim was to evaluate the prevalence of patients at risk of ARFID among individuals with quiescent IBD and IBS-type symptoms, and to evaluate its association with the FODMAP intake.
Methods:
A cross-sectional study was conducted on adult IBD patients followed in a tertiary Belgian center whose recent work-up showed endoscopic and biological remission as per STRIDE II criteria. Self-administered questionnaires (NIAS-Fr, SCOFF-F, FFQ-FODMAP-BE, GAD-7, PHQ-9, IBS SSS, PRO-2, HBI) were completed remotely via REDCap. Univariate and multivariate logistic regressions were performed, with the significant threshold fixed at 5%.
Results:
Sixty-two patients were enrolled (65% female, 66% Crohn's disease, mean age 39 ± 14 years). Overall, 16 patients (26%) were screened positive for ARFID risk. Among these 16 patients, the distribution across subscales (picky eater, small appetite, fear of eating) was as follows: 63% (10/16) fulfilled one subscale, 31% (5/16) fulfilled two subscales, 6% (1/16) fulfilled all three. Higher IBS symptom severity was associated with a higher risk of positive screening for ARFID. In a multivariate logistic regression model, positive screening for risk of ARFID was associated with mild FODMAP consumption (FFQ-FODMAP-BE < 1.80) and anxiety.
Conclusion:
One in four patients with quiescent IBD has a positive screening for ARFID. Anxiety and low FODMAP intakes are associated with positive screening.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:23Irritable Bowel Syndrome
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...